20 (AIDX) Notes Payables (2025 - 2026)
20's (AIDX) quarterly Notes Payables came in at $306716.0 in Q1 2026, up 113.92% quarter-over-quarter from $143382.0 in Q4 2025.
Powered by 
Analysis
20 (AIDX) Notes Payables (2025 - 2026) Analysis & Trends
20 (AIDX) has reported Notes Payables for 2 consecutive years, with $306716.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Notes Payables changed N/A year-over-year to $306716.0; the trailing twelve-month figure through Mar 2026 stood at $306716.0 (changed N/A YoY), and the FY2025 full-year result was $143382.0, changed N/A from the prior year.
- Notes Payables rose to $306716.0 in Q1 2026 per AIDX's latest filing, from $143382.0 in the prior quarter.
- Across five years, Notes Payables topped out at $306716.0 in Q1 2026 and bottomed at $143382.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 46.93 Bn | 45.83 Bn | 486.15 Mn |
| 2 | Labcorp Holdings | 26.05 Bn | 25.90 Bn | 1.11 Bn |
| 3 | Quest Diagnostics | 25.81 Bn | 25.18 Bn | 1.03 Bn |
| 4 | Guardant Health | 21.79 Bn | 20.73 Bn | 219.03 Mn |
| 5 | Tempus AI | 11.14 Bn | 10.33 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 6.90 Bn | 6.11 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.19 Bn | 4.84 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.74 Bn | 4.19 Bn | 77.11 Mn |
| 9 | iRhythm Holdings | 3.97 Bn | 3.38 Bn | 163.21 Mn |
| 10 | 20 | 6.09 Mn | 1.55 Mn | 304,727.00 |